AUS
NZ
UK
CA
USA
IND
.jpg)
_06_03_2026_21_29_34_162131.jpg)
Summary
- JD Sports Plc Director and Remuneration committee head is set to leave the company after shareholders voted against reappointment.
- GlaxoSmithKline sold its Verona-based facility to the Hamburg-based Evotec SE.
- Iconic Labs Plc is looking for potential investors and will conduct its next General Meeting on 13 July.
The lockdown restrictions in the UK are set to ease this month. In the final phase of lockdown relief, the cap on the number of people permitted at the wedding, restaurants will be lifted, and nightclubs and live performances will resume soon. After the final phase of easing, it is expected that demand will be back in the economy, and businesses will operate at full capacity.
Copyright © 2021 Kalkine Media
Let us have a look at 3 FTSE listed companies that are in limelight:
JD Sports Fashion Plc (LON: JD.)
FTSE 100 listed JD Sports is a British retail store company that operates 2488 stores worldwide. The company is into selling sports and outdoor activity merchandise through its retail outlets.
The company has informed that Director and Remuneration committee chair Andrew Leslie will leave the company after 54.65% of shareholders voted against his reappointment to the Board. Andrew Leslie has been on the Company’s Board for the last 11 years, which exceeds the rules set by Britain’s corporate governance code.
The company had previously faced negative criticism from its shareholders for providing a bonus to its CEO Peter Cowgill, especially when the company received government aid in the form of business rates relief and staff furloughed during the Covid-19 Pandemic.
Recently, the company gave guidance on pretax profits and expects a pretax profit of not less than £550 million for the year 2021.
JD Sports stock trades at GBX 970.80, up by 0.19% on 02 July at 08:52 GMT+1 with a market cap of £10 billion.
GlaxoSmithKline Plc (LON: GSK)
The Multinational Pharmaceutical Company operates in the development, manufacturing and marketing of prescribed medicines, vaccines and health-related consumer products. GSK is the world’s sixth-largest pharmaceutical company.
GSK’s research and development facility in Verona, Italy, will be acquired by the Hamburg-based Evotec SE. The site acquisition is key to the company’s global strategic framework, and the facility will be used for drug discovery and development, API manufacturing, service on accelerated drug development as well as cCMP manufacturing. The Verona based facility will be renamed after the acquisition of Italian Nobel laureate Rite Levi-Montaclini.
GSK has recently announced that the company will deliver growth and performance over the next decade driven by the development of high-quality vaccines and a specialty Medicine portfolio.
The GSK shares trade at GBX 1,447, up by 0.66% on 02 July at 08:47 GMT+1 with a market cap of £72.85 billion.
Iconic Labs Plc (LON:ICON):
The company has a media and technology business and provides content creation, online marketing, post-campaign analysis and technology-driven products to its clients. The company works with interaction between community, culture and technology with the aim to focus and capitalise on emerging trends.
The company recently informed that the Board is looking for potential financial supporters so that a viable financial proposal could be presented to the company creditors.
The company’s General Meeting, which was scheduled for 29 June 2021, has been adjourned to 13 July 2021. The General Meeting will take place at the office in London, and Proxy forms submitted previously by the shareholders will remain valid.
The stocks of the company are presently suspended.
